SPONSOR
NRG Oncology
Total Trials
5
Recruiting
5
Phases
Phase 3
Conditions studied: Hematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmOvarian CarcinomaStage I Breast CancerBreast CancerCognitive ImpairmentsMetastatic Lung Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainRecurrent Lung Small Cell CarcinomaStage IV Lung Cancer AJCC v8
NRG Oncology is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm, Ovarian Carcinoma, Stage I Breast Cancer.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — NRG Oncology
How many clinical trials has NRG Oncology sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by NRG Oncology, of which 5 are actively recruiting participants. These trials cover conditions including Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm, Ovarian Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does NRG Oncology research focus on?
NRG Oncology clinical trials span Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm, Ovarian Carcinoma, Stage I Breast Cancer, Breast Cancer, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a NRG Oncology clinical trial?
To participate in a NRG Oncology trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all NRG Oncology trials with current recruitment status updated daily.
Clinical Trials by NRG Oncology
NCT06279013
Recruiting
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
Hematopoietic and Lymphatic System Neoplasm
NCT04251052
Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
NCT05896189
Recruiting
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
Breast Cancer
NCT04804644 Phase 3
Recruiting
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
Metastatic Lung Small Cell Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology